• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

循环外泌体 miR-125a-3p 作为早期结肠癌的新型生物标志物。

Circulating exosomal miR-125a-3p as a novel biomarker for early-stage colon cancer.

机构信息

Department of Oncology, The Second Affiliate Hospital of Harbin Medical University, Harbin, 150081, China.

Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, 150081, China.

出版信息

Sci Rep. 2017 Jun 23;7(1):4150. doi: 10.1038/s41598-017-04386-1.

DOI:10.1038/s41598-017-04386-1
PMID:28646161
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5482839/
Abstract

Circulating exosome holds great potentials as biomarker for diagnosis and prognosis of human cancers. Previously, we have applied small RNA sequencing to identify aberrantly expressed exosomal miRNAs as candidates for diagnostic markers in colon cancer patients. In this validation cohort, plasma derived exosomal miRNA was isolated from 50 early-stage colon cancer patients and 50 matched healthy volunteers. Real-time qRT-PCR revealed that miR-125a-3p, miR-320c were significantly up-regulated in plasma exosomes of the patients with early stage colon cancer. ROC curve showed that miR-125a-3p abundant level may predict colon cancer with an area of under the curve (AUC) of 68.5%, in comparison to that of CEA at 83.6%. Combination of miR-125a-3P and CEA improved the AUC to 85.5%. In addition, plasma exosome level of miR-125a-3p and miR-320c showed significant correlation with nerve infiltration (P < 0.01), but not with tumor size, infiltration depth, and differentiation degree (P > 0.05). On the contrary, plasma CEA level is correlated with tumor size, infiltration depth, and differentiation degree (P < 0.05, r = 0.3009-0.7270), but not with nerve infiltration (P = 0.744). In conclusion, this follow-up study demonstrated circulating plasma exosomal miR-125a-3p is readily accessible as diagnosis biomarker for early-stage colon cancer. When combined with conventional diagnostic markers, miR-125a-3p can improve the diagnostic power.

摘要

循环外泌体作为人类癌症诊断和预后的生物标志物具有巨大的潜力。此前,我们应用小 RNA 测序来鉴定异常表达的外泌体 miRNA,将其作为结肠癌患者诊断标志物的候选者。在本验证队列中,从 50 例早期结肠癌患者和 50 例匹配的健康志愿者中分离出血浆来源的外泌体 miRNA。实时 qRT-PCR 显示,miR-125a-3p、miR-320c 在早期结肠癌患者血浆外泌体中显著上调。ROC 曲线显示,miR-125a-3p 丰度水平可预测结肠癌,曲线下面积(AUC)为 68.5%,而 CEA 为 83.6%。miR-125a-3P 和 CEA 的联合应用可将 AUC 提高至 85.5%。此外,miR-125a-3p 和 miR-320c 的血浆外泌体水平与神经浸润呈显著相关(P<0.01),但与肿瘤大小、浸润深度和分化程度无关(P>0.05)。相反,血浆 CEA 水平与肿瘤大小、浸润深度和分化程度相关(P<0.05,r=0.3009-0.7270),但与神经浸润无关(P=0.744)。总之,这项随访研究表明,循环血浆外泌体 miR-125a-3p 可作为早期结肠癌的诊断标志物。当与常规诊断标志物联合使用时,miR-125a-3p 可以提高诊断能力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0768/5482839/023b72d901a6/41598_2017_4386_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0768/5482839/0127f8bed1e4/41598_2017_4386_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0768/5482839/96f752649010/41598_2017_4386_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0768/5482839/e5e42f49ffe7/41598_2017_4386_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0768/5482839/023b72d901a6/41598_2017_4386_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0768/5482839/0127f8bed1e4/41598_2017_4386_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0768/5482839/96f752649010/41598_2017_4386_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0768/5482839/e5e42f49ffe7/41598_2017_4386_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0768/5482839/023b72d901a6/41598_2017_4386_Fig4_HTML.jpg

相似文献

1
Circulating exosomal miR-125a-3p as a novel biomarker for early-stage colon cancer.循环外泌体 miR-125a-3p 作为早期结肠癌的新型生物标志物。
Sci Rep. 2017 Jun 23;7(1):4150. doi: 10.1038/s41598-017-04386-1.
2
Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs.从血清外泌体 microRNAs 中鉴定慢性萎缩性胃炎的非侵入性生物标志物。
BMC Cancer. 2019 Feb 8;19(1):129. doi: 10.1186/s12885-019-5328-7.
3
Serum exosomal miR-7977 as a novel biomarker for lung adenocarcinoma.血清外泌体 miR-7977 作为肺腺癌的一种新型生物标志物。
J Cell Biochem. 2020 Jun;121(5-6):3382-3391. doi: 10.1002/jcb.29612. Epub 2020 Jan 3.
4
RNA-Seq Identifies Circulating miR-125a-5p, miR-125b-5p, and miR-143-3p as Potential Biomarkers for Acute Ischemic Stroke.RNA-Seq 鉴定出循环 miR-125a-5p、miR-125b-5p 和 miR-143-3p 可作为急性缺血性脑卒中的潜在生物标志物。
Circ Res. 2017 Sep 29;121(8):970-980. doi: 10.1161/CIRCRESAHA.117.311572. Epub 2017 Jul 19.
5
Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.血浆 miRNAs 在胰腺癌的诊断和预后中的作用:一项 miRNA 表达分析。
Gene. 2018 Oct 5;673:181-193. doi: 10.1016/j.gene.2018.06.037. Epub 2018 Jun 18.
6
Circulating Exosomal miRNAs as Novel Biomarkers for Stable Coronary Artery Disease.循环外泌体 miRNA 作为稳定型冠状动脉疾病的新型生物标志物。
Biomed Res Int. 2020 Dec 11;2020:3593962. doi: 10.1155/2020/3593962. eCollection 2020.
7
Serum exosomal miR-4772-3p is a predictor of tumor recurrence in stage II and III colon cancer.血清外泌体miR-4772-3p是II期和III期结肠癌肿瘤复发的一个预测指标。
Oncotarget. 2016 Nov 15;7(46):76250-76260. doi: 10.18632/oncotarget.12841.
8
Circulating serum exosomal as a novel biomarker for early diagnosis of gastric cancer.循环血清外泌体作为一种新型的胃癌早期诊断生物标志物。
Future Oncol. 2021 Mar;17(8):907-919. doi: 10.2217/fon-2020-0792. Epub 2021 Feb 3.
9
Predictive Value of Circulating miRNAs in Lymph Node Metastasis for Colon Cancer.循环 miRNA 在结直肠癌淋巴结转移中的预测价值。
Genes (Basel). 2021 Jan 27;12(2):176. doi: 10.3390/genes12020176.
10
Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.循环外泌体微小RNA作为非小细胞肺癌的预后生物标志物
Oncotarget. 2017 Feb 21;8(8):13048-13058. doi: 10.18632/oncotarget.14369.

引用本文的文献

1
Enhanced Early Detection of Colorectal Cancer via Blood Biomarker Combinations Identified Through Extracellular Vesicle Isolation and Artificial Intelligence Analysis.通过细胞外囊泡分离和人工智能分析确定的血液生物标志物组合实现结直肠癌的强化早期检测。
J Extracell Vesicles. 2025 Jun;14(6):e70088. doi: 10.1002/jev2.70088.
2
Circulating exosomal miR-17-92 cluster serves as a novel noninvasive diagnostic marker for patients with gastric cancer.循环外泌体miR-17-92簇作为胃癌患者一种新型的非侵入性诊断标志物。
World J Gastrointest Oncol. 2025 May 15;17(5):104776. doi: 10.4251/wjgo.v17.i5.104776.
3
Exosome-Based Liquid Biopsy in Early Screening and Diagnosis of Cancers.

本文引用的文献

1
A panel of circulating miRNAs as diagnostic biomarkers for screening multiple myeloma: a systematic review and meta-analysis.一组循环miRNA作为筛查多发性骨髓瘤的诊断生物标志物:系统评价和荟萃分析
Int J Lab Hematol. 2016 Dec;38(6):589-599. doi: 10.1111/ijlh.12560.
2
Identification of suitable reference gene and biomarkers of serum miRNAs for osteoporosis.鉴定用于骨质疏松症的血清 miRNAs 的合适参考基因和生物标志物。
Sci Rep. 2016 Nov 8;6:36347. doi: 10.1038/srep36347.
3
Prognostic Survival Associated With Left-Sided vs Right-Sided Colon Cancer: A Systematic Review and Meta-analysis.
基于外泌体的液体活检在癌症早期筛查与诊断中的应用
Dose Response. 2025 May 28;23(2):15593258251344480. doi: 10.1177/15593258251344480. eCollection 2025 Apr-Jun.
4
The role of miRNAs in the pathogenesis, diagnosis, and treatment of colorectal cancer and colitis-associated cancer.微小RNA在结直肠癌及结肠炎相关癌的发病机制、诊断和治疗中的作用。
Clin Exp Med. 2025 Mar 16;25(1):86. doi: 10.1007/s10238-025-01582-6.
5
Relationship between exosomes and cancer: formation, diagnosis, and treatment.外泌体与癌症的关系:形成、诊断及治疗
Int J Biol Sci. 2025 Jan 1;21(1):40-62. doi: 10.7150/ijbs.95763. eCollection 2025.
6
Advances in microRNAs as Emerging Biomarkers for Colorectal Cancer Early Detection and Diagnosis.微小 RNA 作为结直肠癌早期检测和诊断的新兴生物标志物的研究进展。
Int J Mol Sci. 2024 Oct 15;25(20):11060. doi: 10.3390/ijms252011060.
7
Identification of miRNAs Present in Cell- and Plasma-Derived Extracellular Vesicles-Possible Biomarkers of Colorectal Cancer.细胞和血浆来源的细胞外囊泡中存在的miRNA的鉴定——结直肠癌可能的生物标志物
Cancers (Basel). 2024 Jul 5;16(13):2464. doi: 10.3390/cancers16132464.
8
Tumor-Derived Extracellular Vesicles as Liquid Biopsy for Diagnosis and Prognosis of Solid Tumors: Their Clinical Utility and Reliability as Tumor Biomarkers.肿瘤衍生的细胞外囊泡作为实体瘤诊断和预后的液体活检:其作为肿瘤生物标志物的临床实用性和可靠性
Cancers (Basel). 2024 Jul 5;16(13):2462. doi: 10.3390/cancers16132462.
9
Extracellular vesicle biomarkers in circulation for colorectal cancer detection: a systematic review and meta-analysis.循环中外泌体标志物在结直肠癌检测中的应用:系统评价和荟萃分析。
BMC Cancer. 2024 May 22;24(1):623. doi: 10.1186/s12885-024-12312-8.
10
Prospects of liquid biopsy in the prognosis and clinical management of gastrointestinal cancers.液体活检在胃肠道癌症预后及临床管理中的前景
Front Mol Biosci. 2024 May 6;11:1385238. doi: 10.3389/fmolb.2024.1385238. eCollection 2024.
左半结肠癌与右半结肠癌的预后生存情况:一项系统评价与荟萃分析
JAMA Oncol. 2017 Feb 1;3(2):211-219. doi: 10.1001/jamaoncol.2016.4227.
4
Colorectal cancer incidence and survival by sub-site and stage of diagnosis: a population-based study at the advent of national screening.按诊断亚部位和阶段划分的结直肠癌发病率及生存率:一项基于人群的国家筛查起始阶段研究
Ir J Med Sci. 2017 Feb;186(1):113-121. doi: 10.1007/s11845-016-1513-8. Epub 2016 Oct 18.
5
Enforced expression of hsa-miR-125a-3p in breast cancer cells potentiates docetaxel sensitivity via modulation of BRCA1 signaling.在乳腺癌细胞中强制表达hsa-miR-125a-3p可通过调节BRCA1信号增强多西他赛敏感性。
Biochem Biophys Res Commun. 2016 Oct 28;479(4):893-900. doi: 10.1016/j.bbrc.2016.09.087. Epub 2016 Sep 28.
6
Plasma exosome microRNAs are indicative of breast cancer.血浆外泌体微小RNA可作为乳腺癌的指示物。
Breast Cancer Res. 2016 Sep 8;18(1):90. doi: 10.1186/s13058-016-0753-x.
7
Serum-based microRNA signatures in early diagnosis and prognosis prediction of colon cancer.基于血清的微小RNA特征在结肠癌早期诊断和预后预测中的应用
Carcinogenesis. 2016 Oct;37(10):941-950. doi: 10.1093/carcin/bgw078. Epub 2016 Aug 1.
8
Clinical relevance of circulating cell-free microRNAs in ovarian cancer.循环游离微小RNA在卵巢癌中的临床相关性
Mol Cancer. 2016 Jun 24;15(1):48. doi: 10.1186/s12943-016-0536-0.
9
Targeted next-generation sequencing for the detection of ciprofloxacin resistance markers using molecular inversion probes.使用分子倒置探针进行靶向新一代测序以检测环丙沙星耐药标志物
Sci Rep. 2016 May 13;6:25904. doi: 10.1038/srep25904.
10
Exosome-encapsulated microRNAs as circulating biomarkers for breast cancer.外泌体包裹的微小RNA作为乳腺癌的循环生物标志物
Int J Cancer. 2016 Oct 1;139(7):1443-8. doi: 10.1002/ijc.30179. Epub 2016 May 31.